Meningococcal group B (MenB) vaccine - About the MenB vaccine
Background
Meningococcal disease is a life-threatening infection. Meningococcal disease is the term used to describe two serious illnesses – meningitis and septicaemia.
MenB vaccine
The MenB vaccine is the safest and most effective way to help protect against meningitis and septicaemia caused by meningococcal bacteria group B.
It is important to protect children against meningococcal disease by making sure they get their infant MenB vaccinations and teenagers get their MenACWY vaccination in school.
Check your child’s red book or with your GP surgery and get your child vaccinated if they are not up to date.
Eligibility for the vaccine
About the vaccine
Babies will normally be given the MenB vaccine as an injection in their upper leg (thigh). Older children and adults will normally have it as an injection in their upper arm.
The MenB vaccine, Bexsero, is the only vaccine currently available in the UK that offers protection against meningococcal group B bacteria.
Babies will need three doses of the MenB vaccine to be fully protected. Children who have missed vaccinations and had less than two doses of MenB vaccine in the first year of life should have further doses before they reach two years of age.
MenB vaccine is not routinely given to children over two years old unless they are in an at-risk group. For example, children who have certain problems with their immune system.
Safety and effectiveness
Resources
If you would like to learn more about the MenB vaccine or the diseases it protects against, a number of information resources are available to help. You can also call NHS 111 or your GP surgery for advice if you have any questions.
MenB outbreak
More information
- Meningitis Research Foundation is a leading UK, Irish and international charity that brings together people and expertise to defeat meningitis.
- Meningitis Now is a national meningitis charity based in the United Kingdom.
Page last reviewed: 13th April 2026